Methods for in vitro evaluating antimicrobial activity: A review
Tóm tắt
Từ khóa
Tài liệu tham khảo
Mayers, 2009, vol. 2
Guschin, 2015, Treatment efficacy, treatment failures and selection of macrolide resistance in patients with high load of Mycoplasma genitalium during treatment of male urethritis with Josamycin, BMC Infect. Dis., 15, 1, 10.1186/s12879-015-0781-7
Martin, 2015, Antimicrobial resistance to Neisseria gonorrhoeae in Canada: 2009–2013, Can. Commun. Dis. Rep., 41, 40, 10.14745/ccdr.v41i02a04
Runyoro, 2006, Screening of Tanzanian medicinal plants for anti-Candida activity, BMC Complement. Altern. Med., 6, 11, 10.1186/1472-6882-6-11
Mabona, 2013, Antimicrobial activity of Southern African medicinal plants with dermatological relevance: from an ethnopharmacological screening approach, to combination studies and the isolation of a bioactive compound, J. Ethnopharmacol., 148, 45, 10.1016/j.jep.2013.03.056
Nazzaro, 2013, Effect of essential oils on pathogenic bacteria, Pharmaceuticals, 6, 1451, 10.3390/ph6121451
CLSI, Performance Standards for Antimicrobial Disk Susceptibility Tests, Approved Standard, 7th ed., CLSI document M02-A11. Clinical and Laboratory Standards Institute, 950 West Valley Road, Suite 2500, Wayne, Pennsylvania 19087, USA, 2012.
CLSI, Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts, Approved Guideline. CLSI document M44-A. CLSI, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898, USA, 2004.
Jorgensen, 2009, Antimicrobial susceptibility testing: a review of general principles and contemporary practices, Clin. Infect. Dis., 49, 1749, 10.1086/647952
Caron, 2012, Antimicrobial susceptibility testing : a four facets tool for the clinician, J. Des. Anti-Infect., 14
Nijs, 2003, Comparison and evaluation of Osiris and Sirscan 2000 antimicrobial susceptibility systems in the clinical microbiology laboratory, J. Clin. Microbiol., 41, 3627, 10.1128/JCM.41.8.3627-3630.2003
Kreger, 1980, Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients, Am. J. Med., 68, 344, 10.1016/0002-9343(80)90102-3
Lopez-Oviedo, 2006, Evaluation of disk diffusion method for determining posaconazole susceptibility of filamentous fungi : comparison with CLSI broth microdilution method, Antimicrob. Agents Chemother., 50, 1108, 10.1128/AAC.50.3.1108-1111.2006
Arikan, 2003, Comparison of two methods and three end points in determination of in vitro activity of Micafungin against Aspergillus spp, Antimicrob. Agents Chemother., 47, 2640, 10.1128/AAC.47.8.2640-2643.2003
Arikan, 2002, Comparative evaluation of disk diffusion with microdilution assay in susceptibility testing of caspofungin against Aspergillus and Fusarium isolates, Antimicrob. Agents Chemother., 46, 3084, 10.1128/AAC.46.9.3084-3087.2002
CLSI, Method for Antifungal Disk Diffusion Susceptibility Testing of Nondermatophyte Filamentous Fungi, Approved guideline, CLSI document M51-A. Clincal and Laboratory Standards Institute, 950 West Valley Roead, Suite 2500, Wayne, Pennsylvania 19087, USA, 2010.
Espinel-Ingroff, 2011, Quality control guidelines for amphotericin B, itraconazole, posaconazole, and Voriconazole disk diffusion susceptibility tests with nonsupplemented Mueller–Hinton Agar (CLSI M51-A document) for nondermatophyte Filamentous Fungi, J. Clin. Microbiol., 49, 2568, 10.1128/JCM.00393-11
Fourati-Ben Fguira, 2005, Purification and structure elucidation of antifungal and antibacterial activities of newly isolated Streptomyces sp. strain US80, Res. Microbiol., 156, 341, 10.1016/j.resmic.2004.10.006
Konaté, 2012, Antibacterial activity against β-lactamase producing Methicillin and Ampicillin-resistants Staphylococcus aureus: Fractional Inhibitory Concentration Index (FICI) determination, Ann. Clin. Microbiol. Antimicrob., 11, 18, 10.1186/1476-0711-11-18
De Billerbeck, 2007, Huiles Essentielles et Bactéries Résistantes aux Antibiotiques, Phytotherapie, 5, 249, 10.1007/s10298-007-0265-z
Das, 2010, Techniques for evaluation of medicinal plant products as antimicrobial agents: current methods and future trends, J. Med. Plants Res., 4, 104
Hausdorfer, 1998, E-test for susceptibility testing of Mycobacterium tuberculosis, Int. J. Tuberc. Lung Dis., 2, 751
Baker, 1991, Comparison of the E Test to agar dilution, broth microdilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria, J. Clin. Microbiol., 29, 533, 10.1128/JCM.29.3.533-538.1991
Berghaus, 2015, Comparison of Etest, disk diffusion, and broth macrodilution for in vitro susceptibility testing of Rhodococcus equi, J. Clin. Microbiol., 53, 314, 10.1128/JCM.02673-14
Gupta, 2015, Comparative evaluation of disc diffusion and E-test with broth micro-dilution in susceptibility testing of amphotericin B, voriconazole and caspofungin against clinical Aspergillus isolates, J. Clin. Diagn. Res., 9, 2013
White, 1996, Comparison of three different in vitro methods of detecting synergy : time-kill, checkerboard, and E test, Antimicrob. Agents Chemother., 40, 1914, 10.1128/AAC.40.8.1914
Denes, 2009, Synergie et Antagonisme en Antibiothérapie, Antibiotiques, 11, 106, 10.1016/j.antib.2009.02.001
Gülmez, 2010, Comparison of different antimicrobial susceptibility testing methods for Stenotrophomonas maltophilia and results of synergy testing, J. Infect. Chemother., 16, 322, 10.1007/s10156-010-0068-2
Bassolé, 2012, Essential oils in combination and their antimicrobial properties, Molecules, 17, 3989, 10.3390/molecules17043989
Magaldi, 2004, Well diffusion for antifungal susceptibility testing, Int. J. Infect. Dis., 8, 39, 10.1016/j.ijid.2003.03.002
Valgas, 2007, Screening methods to determine antibacterial activity of natural products, Braz. J. Microbiol., 38, 369, 10.1590/S1517-83822007000200034
Jiménez-Esquilín, 2005, Antifungal activities of actinomycete strains associated with high-altitude Sagebrush Rhizosphere, J. Ind. Microbiol. Biotechnol., 32, 378, 10.1007/s10295-005-0007-x
Elleuch, 2010, Bioactive secondary metabolites from a new terrestrial Streptomyces sp. TN262, Appl. Biochem. Biotechnol., 162, 579, 10.1007/s12010-009-8808-4
Lertcanawanichakul, 2008, A comparison of two methods used for measuring the antagonistic activity of Bacillus species, Walailak J. Sci. Tech., 5, 161
Ali-Shtayeh, 1999, Antifungal activity of plant extracts against Dermatophytes, Mycoses, 42, 665, 10.1046/j.1439-0507.1999.00499.x
Mukherjee, 1997, Effect of temperature on antagonistic and biocontrol potential of Trichoderma sp. on Sclerotium rolfsii, Mycopathologia, 139, 151, 10.1023/A:1006868009184
Kumar, 2013, Isolation and identification of antimicrobial secondary metabolites from Bacillus cereus associated with a Rhabditid Entomopathogenic Nematode, Ann. Microbiol., 64, 209, 10.1007/s13213-013-0653-6
Goodall, 1946, A microchromatographic method for the detection and approximate determination of the different penicillins in a mixture, Nature, 158, 675, 10.1038/158675a0
Fischer, 1961, On the paper chromatographic detection of penicillin preparations, Arch. Pharm., 294, 1, 10.1002/ardp.19612940102
Horváth, 2010, Antimicrobial activity of essential oils: the possibilities of TLC-bioautography, Flavour Fragr. J., 25, 178, 10.1002/ffj.1993
Mehrabani, 2013, Evaluation of antifungal activities of Myrtus communis L. by bioautography method, Jundishapur J. Microbiol., 6, 1, 10.5812/jjm.8316
Marston, 2011, Thin-layer chromatography with biological detection in phytochemistry, J. Chromatogr. A, 1218, 2676, 10.1016/j.chroma.2010.12.068
Dewanjee, 2015, Bioautography and its scope in the field of natural product chemistry, J. Pharm. Anal., 5, 75, 10.1016/j.jpha.2014.06.002
Choma, 2011, Bioautography detection in thin-layer chromatography, J. Chromatogr. A, 1218, 2684, 10.1016/j.chroma.2010.12.069
Grzelak, 2011, Development of a novel direct bioautography-thin-layer chromatography test: optimization of growth conditions for gram-negative bacteria, Escherichia coli, J. AOAC Int., 94, 1567, 10.5740/jaoac.10-385
Brantner, 1997, Influence of various parameters on the evaluation of antibacterial compounds by the bioautographic TLC assay, Pharm. Pharmacol. Lett., 7, 152
Silva, 2005, Studies on antimicrobial activity, in vitro, of Physalis angulata L. (Solanaceae) fraction and Physalin B bringing out the importance of assay determination, Mem. Inst. Oswaldo Cruz, 100, 779, 10.1590/S0074-02762005000700018
Shahat, 2008, Chemical composition and antimicrobial activities of the essential oil from the seeds of Enterolobium contortisiliquum (leguminosae), J. Environ. Sci. Health. B, 43, 519, 10.1080/03601230802174714
Suleiman, 2010, Detection of antimicrobial compounds by bioautography of different extracts of leaves of selected South African tree species, Afr. J. Tradit. Complement. Altern. Med., 7, 64, 10.4314/ajtcam.v7i1.57269
Homans, 1970, Direct bioautography on thin-layer chromatograms as a method for detecting fungitoxic substances, J. Chromatogr. A, 51, 327, 10.1016/S0021-9673(01)96877-3
Hamburger, 1987, A direct bioautographic TLC assay for compounds possessing antibacterial activity, J. Nat. Prod., 50, 19, 10.1021/np50049a003
Balouiri, 2015, Antifungal activity of Bacillus spp. isolated from Calotropis procera AIT. Rhizosphere against Candida albicans, Asian J. Pham. Clin. Res., 8, 213
Pfaller, 2004, Determination of fungicidal activities against yeasts and molds: lessons learned from bactericidal testing and the need for standardization, Clin. Microbiol. Rev., 17, 268, 10.1128/CMR.17.2.268-280.2004
CLSI, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, Approved Standard, 9th ed., CLSI document M07-A9. Clinical and Laboratory Standards Institute, 950 West Valley Road, Suite 2500, Wayne, Pennsylvania 19087, USA, 2012
Al-Bakri, 2007, Evaluation of antimicrobial activity of selected plant extracts by rapid XTT colorimetry and bacterial enumeration, J. Microbiol. Methods, 68, 19, 10.1016/j.mimet.2006.05.013
Liang, 2012, Antimicrobial activities of endophytic fungi isolated from Ophiopogon japonicus (Liliaceae), BMC Complement. Altern. Med., 12, 238, 10.1186/1472-6882-12-238
Monteiro, 2012, A new approach to drug discovery: high-throughput screening of microbial natural extracts against Aspergillus fumigatus using resazurin, J. Biomol. Screen., 17, 524, 10.1177/1087057111433459
Kuhn, 2003, Uses and limitations of the XTT assay in studies of Candida growth and metabolism, J. Clin. Microbiol., 41, 506, 10.1128/JCM.41.1.506-508.2003
Reis, 2004, Comparison of flow cytometric and alamar blue tests with the proportional method for testing susceptibility of Mycobacterium tuberculosis to Rifampin and Isoniazid, J. Clin. Microbiol., 42, 2247, 10.1128/JCM.42.5.2247-2248.2004
Ouedrhiri, 2015, Chemical composition of Citrus aurantium L. Leaves and zest essential oils, their antioxidant, antibacterial single and combined effects, J. Chem. Pharm. Res., 7, 78
Bouhdid, 2009, Investigation of functional and morphological changes in Pseudomonas aeruginosa and Staphylococcus aureus cells induced by Origanum compactum essential oil, J. Appl. Microbiol., 106, 1558, 10.1111/j.1365-2672.2008.04124.x
Castilho, 2015, Detection of drug susceptibility in rapidly growing mycobacteria by Resazurin broth microdilution assay, J. Microbiol. Methods, 111, 119, 10.1016/j.mimet.2015.02.007
Gehrt, 1995, Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by Broth microdilution method, J. Clin. Microbiol., 33, 1302, 10.1128/JCM.33.5.1302-1307.1995
Meletiadis, 2001, Analysis of growth characteristics of filamentous fungi in different nutrient media, J. Clin. Microbiol., 39, 478, 10.1128/JCM.39.2.478-484.2001
Gomez-Lopez, 2005, Analysis of the influence of tween concentration, inoculum size, assay medium, and reading time on susceptibility testing of Aspergillus spp, J. Clin. Microbiol., 43, 1251, 10.1128/JCM.43.3.1251-1255.2005
Rodriguez-Tudela, 2003, Interlaboratory evaluation of hematocytometer method of inoculum preparation for testing antifungal susceptibilities of filamentous fungi, J. Clin. Microbiol., 41, 5236, 10.1128/JCM.41.11.5236-5237.2003
CLSI, Reference Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts, Approved Standard, 2nd ed., NCCLS document M27-A2. CLSI, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898, USA, 2002.
CLSI, Reference Method for Broth Dilution Antifungal Susceptibility Testing Filamentous Fungi, Approved Standard, 2nd ed., CLSI document M38-A2, 950 West Valley Roadn Suite 2500,Wayne, Pennsylvania 19087, USA, 2008.
Arikan, 2007, Current status of antifungal susceptibility testing methods, Med. Mycol., 45, 569, 10.1080/13693780701436794
Lass-Flörl, 2006, Antifungal susceptibility testing in Aspergillus spp. according to EUCAST methodology, Med. Mycol., 44, 319, 10.1080/13693780600779401
Petrikkou, 2001, Inoculum standardization for antifungal susceptibility testing of filamentous fungi pathogenic for humans, J. Clin. Microbiol., 39, 1345, 10.1128/JCM.39.4.1345-1347.2001
Aberkane, 2002, Comparative evaluation of two different methods of inoculum preparation for antifungal susceptibility testing of filamentous fungi, J. Antimicrob. Chemother., 50, 719, 10.1093/jac/dkf187
CLSI, Methods for Determining Bactericidal Activity of Antimicrobial Agents. Approved Guideline, CLSI document M26-A. Clinical and Laboratory Standards Institute, 950 West Valley Roadn Suite 2500,Wayne, Pennsylvania 19087, USA, 1998.
Cantón, 2003, Minimum fungicidal concentrations of amphotericin B for bloodstream Candida species, Diagn. Microbiol. Infect. Dis., 45, 203, 10.1016/S0732-8893(02)00525-4
Espinel-Ingroff, 2002, Testing conditions for determination of minimum fungicidal concentrations of new and established antifungal agents for Aspergillus spp.: NCCLS collaborative study, J. Clin. Microbiol., 40, 3204, 10.1128/JCM.40.9.3204-3208.2002
Espinel-Ingroff, 2002, Optimal testing conditions for determining MICs and minimum fungicidal concentrations of new and established antifungal agents for uncommon molds: NCCLS collaborative study, J. Clin. Microbiol., 40, 3776, 10.1128/JCM.40.10.3776-3781.2002
CLSI, Methods for Antimicrobial Dilution and Disk Susceptibility of Infrequently Isolated or Fastidious Bacteria, Approved Guideline, 2nd. ed., CLSI document M45-A2. Clinical and Laboratory Standards Institute, 950 West Valley Roadn Suite 2500,Wayne, Pennsylvania 19087, USA, 2010.
Menon, 2001, Efficacy of fluconazole and itraconazole in the treatment of oral candidiasis in HIV patients, Acta Trop., 80, 151, 10.1016/S0001-706X(01)00170-X
Imhof, 2003, New methods to assess susceptibilities of Aspergillus isolates to caspofungin, J. Clin. Microbiol., 41, 5683, 10.1128/JCM.41.12.5683-5688.2003
Mock, 1998, Tinea capitis dermatophytes: susceptibility to antifungal drugs tested in vitro and in vivo, Dermatology, 197, 361, 10.1159/000018032
Speeleveld, 1996, Susceptibility of clinical isolates of Fusarium to antifungal drugs, Mycoses, 39, 37, 10.1111/j.1439-0507.1996.tb00081.x
Clancy, 2006, Characterizing the effects of caspofungin on Candida albicans, Candida parapsilosis, and Candida glabrata isolates by simultaneous time-kill and postantifungal-effect experiments, Antimicrob. Agents Chemother., 50, 2569, 10.1128/AAC.00291-06
Klepser, 1998, Influence of test conditions on antifungal time-kill curve results: proposal for standardized methods, Antimicrob. Agents Chemother., 42, 1207, 10.1128/AAC.42.5.1207
Crouch, 1993, The use of ATP Bioluminescence as a measure of cell proliferation and cytotoxicity, J. Immunol. Methods, 160, 81, 10.1016/0022-1759(93)90011-U
Bozorg, 2015, Bacterial bioluminescence to evaluate the impact of biofilm on porous media hydraulic properties, J. Microbiol. Methods, 109, 84, 10.1016/j.mimet.2014.11.015
Paloque, 2013, A new, rapid and sensitive bioluminescence assay for drug screening on Leishmania, J. Microbiol. Methods, 95, 320, 10.1016/j.mimet.2013.09.006
Finger, 2013, Antibacterial properties of cyclodextrin–antiseptics–complexes determined by microplate laser nephelometry and ATP bioluminescence assay, Int. J. Pharm., 452, 188, 10.1016/j.ijpharm.2013.04.080
Andreu, 2012, Rapid measurement of antituberculosis drug activity in vitro and in macrophages using bioluminescence, J. Antimicrob. Chemother., 67, 404, 10.1093/jac/dkr472
Beckers, 1985, Evaluation of a bioluminescence assay for rapid antimicrobial susceptibility testing of mycobacteria, Eur. J. Clin. Microbiol., 4, 556, 10.1007/BF02013394
Finger, 2012, Antimicrobial properties of cyclodextrin–antiseptics-complexes determined by microplate laser nephelometry and ATP bioluminescence assay, Int. J. Pharm., 436, 851, 10.1016/j.ijpharm.2012.07.009
Galiger, 2013, Assessment of efficacy of antifungals against Aspergillus fumigatus : value of real-time bioluminescence imaging, Antimicrob. Agents Chemother., 57, 3046, 10.1128/AAC.01660-12
Vojtek, 2014, Bioluminescent assay for evaluating antimicrobial activity in insect haemolymph, Eur. J. Entomol., 111, 335, 10.14411/eje.2014.045
Paparella, 2008, Flow cytometric assessment of the antimicrobial activity of essential oils against Listeria monocytogenes, Food Control., 19, 1174, 10.1016/j.foodcont.2008.01.002
Ramani, 2000, Flow cytometry antifungal susceptibility testing of pathogenic yeasts other than Candida albicans and comparison with the NCCLS broth microdilution test, Antimicrob. Agents Chemother., 44, 2752, 10.1128/AAC.44.10.2752-2758.2000
Green, 1999, LY303366 exhibits rapid and potent fungicidal activity in flow cytometric assays of yeast viability, Antimicrob. Agents Chemother., 43, 830, 10.1128/AAC.43.4.830
Green, 1994, Rapid determination of antifungal activity by flow cytometry, J. Clin. Microbiol., 32, 1088, 10.1128/JCM.32.4.1088-1091.1994
Ramani, 1997, Rapid flow cytometric susceptibility testing of Candida albicans, J. Clin. Microbiol., 35, 2320, 10.1128/JCM.35.9.2320-2324.1997
Yousef, 2003, Basics of stress adaptation and implications in new-generation foods, 2
Tang, 2013